Cargando…
The role of biomarkers in the management of bone-homing malignancies
Bone represents a common site of metastasis from several solid tumours, including breast, prostate and lung malignancies. The onset of bone metastases (BM) is associated not only with serious skeletal complications, but also shortened overall survival, owing to the lack of curative treatment options...
Autores principales: | D’Oronzo, Stella, Brown, Janet, Coleman, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602513/ https://www.ncbi.nlm.nih.gov/pubmed/28948139 http://dx.doi.org/10.1016/j.jbo.2017.09.001 |
Ejemplares similares
-
Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management
por: D'Oronzo, Stella, et al.
Publicado: (2018) -
Cancer Treatment and Bone Health
por: Handforth, Catherine, et al.
Publicado: (2018) -
Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences
por: D'Oronzo, Stella, et al.
Publicado: (2021) -
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
por: D’Oronzo, Stella, et al.
Publicado: (2020) -
Ddx4(+) Oogonial Stem Cells in Postmenopausal Women’s Ovaries: A Controversial, Undefined Role
por: Silvestris, Erica, et al.
Publicado: (2019)